Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COR
3451
DELISTED
Coresite Realty Corporation
COR
| $1.18M | ﹤0.01% |
9,646
-8,917
| -48% | -$1.02M |
|
|
CLDR
3452
PUT
DELISTED
Cloudera, Inc.
CLDR
| $1.18M | ﹤0.01% |
132,600
+900
| +0.7% | +$6.25K |
|
|
GHL
3453
DELISTED
Greenhill & Co., Inc.
GHL
| $1.17M | ﹤0.01% |
89,162
+23,683
| +36% | +$339K |
|
3454
PUT
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.43B
| $1.17M | ﹤0.01% |
22,300
+15,300
| +219% | +$792K |
|
3455
AppFolio
APPF
$7.01B
| $1.17M | ﹤0.01% |
12,247
+2,370
| +24% | +$236K |
|
|
HEES
3456
DELISTED
H&E Equipment Services
HEES
| $1.16M | ﹤0.01% |
40,356
-4,634
| -10% | -$125K |
|
3457
PUT
Nektar Therapeutics
NKTR
$2.51B
| $1.16M | ﹤0.01% |
4,260
-1,447
| -25% | -$531K |
|
3458
VICI Properties
VICI
$29.3B
| $1.16M | ﹤0.01% |
51,391
-381,208
| -88% | -$8.32M |
|
|
TRHC
3459
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.16M | ﹤0.01% |
21,195
-399
| -2% | -$22.8K |
|
3460
Harmonic Inc
HLIT
$1.28B
| $1.16M | ﹤0.01% |
176,299
+75,008
| +74% | +$520K |
|
3461
CALL
Knight Transportation
KNX
$11.4B
| $1.16M | ﹤0.01% |
31,900
+16,800
| +111% | +$584K |
|
3462
CorVel
CRVL
$3.22B
| $1.16M | ﹤0.01% |
45,912
+8,097
| +21% | +$230K |
|
3463
CALL
Keurig Dr Pepper
KDP
$40.9B
| $1.16M | ﹤0.01% |
42,300
-9,600
| -18% | -$268K |
|
3464
Ultragenyx Pharmaceutical
RARE
$2.52B
| $1.16M | ﹤0.01% |
27,047
-8,287
| -23% | -$450K |
|
|
POLY
3465
DELISTED
Plantronics, Inc.
POLY
| $1.16M | ﹤0.01% |
30,930
-14,633
| -32% | -$498K |
|
3466
Renasant Corp
RNST
$3.94B
| $1.15M | ﹤0.01% |
32,915
-5,078
| -13% | -$174K |
|
3467
The RMR Group
RMR
$329M
| $1.15M | ﹤0.01% |
25,335
+12,067
| +91% | +$568K |
|
|
MIME
3468
DELISTED
Mimecast Limited
MIME
| $1.15M | ﹤0.01% |
32,302
-6,157
| -16% | -$268K |
|
|
EIDX
3469
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $1.15M | ﹤0.01% |
32,028
+4,510
| +16% | +$176K |
|
3470
CALL
Fidelity National Information Services
FIS
$21.9B
| $1.15M | ﹤0.01% |
8,644
-4,056
| -32% | -$539K |
|
|
CERN
3471
PUT
DELISTED
Cerner Corp
CERN
| $1.15M | ﹤0.01% |
16,800
-21,800
| -56% | -$1.54M |
|
3472
CALL
Constellium
CSTM
$4B
| $1.14M | ﹤0.01% |
+90,000
| New | +$1.06M |
|
3473
Artivion
AORT
$1.34B
| $1.14M | ﹤0.01% |
42,113
-29,377
| -41% | -$832K |
|
3474
Koppers
KOP
$957M
| $1.14M | ﹤0.01% |
39,120
-3,534
| -8% | -$98K |
|
3475
PUT
Truist Financial
TFC
$64.1B
| $1.14M | ﹤0.01% |
21,400
-153,000
| -88% | -$7.58M |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.